Cargando…

The Structural Determinants of Insulin-Like Peptide 3 Activity

Insulin-like peptide 3 (INSL3) is a hormone and/or paracrine factor which is a member of the relaxin peptide family. It has key roles as a fertility regulator in both males and females. The receptor for INSL3 is the leucine rich repeat (LRR) containing G-protein coupled receptor 8 (LGR8) which is no...

Descripción completa

Detalles Bibliográficos
Autores principales: Bathgate, Ross A. D., Zhang, Soude, Hughes, Richard A., Rosengren, K. Johan, Wade, John D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356098/
https://www.ncbi.nlm.nih.gov/pubmed/22654853
http://dx.doi.org/10.3389/fendo.2012.00011
_version_ 1782233499447590912
author Bathgate, Ross A. D.
Zhang, Soude
Hughes, Richard A.
Rosengren, K. Johan
Wade, John D.
author_facet Bathgate, Ross A. D.
Zhang, Soude
Hughes, Richard A.
Rosengren, K. Johan
Wade, John D.
author_sort Bathgate, Ross A. D.
collection PubMed
description Insulin-like peptide 3 (INSL3) is a hormone and/or paracrine factor which is a member of the relaxin peptide family. It has key roles as a fertility regulator in both males and females. The receptor for INSL3 is the leucine rich repeat (LRR) containing G-protein coupled receptor 8 (LGR8) which is now known as relaxin family peptide receptor 2 (RXFP2). Receptor activation by INSL3 involves binding to the LRRs in the large ectodomain of RXFP2 by residues within the B-chain of INSL3 as well as an interaction with the transmembrane exoloops of the receptor. Although the binding to the LRRs is well characterized the features of the peptide and receptor involved in the exoloop interaction are currently unknown. This study was designed to determine the key INSL3 determinants for RXFP2 activation. A chimeric peptide approach was first utilized to demonstrate that the A-chain is critical for receptor activation. Replacement of the INSL3 A-chain with that from the related peptides INSL5 and INSL6 resulted in complete loss of activity despite only minor changes in binding affinity. Subsequent replacement of specific A-chain residues with those from the INSL5 peptide highlighted that the N-terminus of the A-chain of INSL3 is critical for its activity. Remarkably, replacement of the entire N-terminus with four or five alanine residues resulted in peptides with near native activity suggesting that specific residues are not necessary for activity. Additionally removal of two amino acids at the C-terminus of the A-chain and mutation of Lys-8 in the B-chain also resulted in minor decreases in peptide activity. Therefore we have demonstrated that the activity of the INSL3 peptide is driven predominantly by residues 5–9 in the A-chain, with minor additional contributions from the two C-terminal A-chain residues and Lys-8 in the B-chain. Using this new knowledge, we were able to produce a truncated INSL3 peptide structure which retained native activity, despite having 14 fewer residues than the parent peptide.
format Online
Article
Text
id pubmed-3356098
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Frontiers Research Foundation
record_format MEDLINE/PubMed
spelling pubmed-33560982012-05-31 The Structural Determinants of Insulin-Like Peptide 3 Activity Bathgate, Ross A. D. Zhang, Soude Hughes, Richard A. Rosengren, K. Johan Wade, John D. Front Endocrinol (Lausanne) Endocrinology Insulin-like peptide 3 (INSL3) is a hormone and/or paracrine factor which is a member of the relaxin peptide family. It has key roles as a fertility regulator in both males and females. The receptor for INSL3 is the leucine rich repeat (LRR) containing G-protein coupled receptor 8 (LGR8) which is now known as relaxin family peptide receptor 2 (RXFP2). Receptor activation by INSL3 involves binding to the LRRs in the large ectodomain of RXFP2 by residues within the B-chain of INSL3 as well as an interaction with the transmembrane exoloops of the receptor. Although the binding to the LRRs is well characterized the features of the peptide and receptor involved in the exoloop interaction are currently unknown. This study was designed to determine the key INSL3 determinants for RXFP2 activation. A chimeric peptide approach was first utilized to demonstrate that the A-chain is critical for receptor activation. Replacement of the INSL3 A-chain with that from the related peptides INSL5 and INSL6 resulted in complete loss of activity despite only minor changes in binding affinity. Subsequent replacement of specific A-chain residues with those from the INSL5 peptide highlighted that the N-terminus of the A-chain of INSL3 is critical for its activity. Remarkably, replacement of the entire N-terminus with four or five alanine residues resulted in peptides with near native activity suggesting that specific residues are not necessary for activity. Additionally removal of two amino acids at the C-terminus of the A-chain and mutation of Lys-8 in the B-chain also resulted in minor decreases in peptide activity. Therefore we have demonstrated that the activity of the INSL3 peptide is driven predominantly by residues 5–9 in the A-chain, with minor additional contributions from the two C-terminal A-chain residues and Lys-8 in the B-chain. Using this new knowledge, we were able to produce a truncated INSL3 peptide structure which retained native activity, despite having 14 fewer residues than the parent peptide. Frontiers Research Foundation 2012-02-01 /pmc/articles/PMC3356098/ /pubmed/22654853 http://dx.doi.org/10.3389/fendo.2012.00011 Text en Copyright © 2012 Bathgate, Zhang, Hughes, Rosengren and Wade. http://www.frontiersin.org/licenseagreement This is an open-access article distributed under the terms of the Creative Commons Attribution Non Commercial License, which permits non-commercial use, distribution, and reproduction in other forums, provided the original authors and source are credited.
spellingShingle Endocrinology
Bathgate, Ross A. D.
Zhang, Soude
Hughes, Richard A.
Rosengren, K. Johan
Wade, John D.
The Structural Determinants of Insulin-Like Peptide 3 Activity
title The Structural Determinants of Insulin-Like Peptide 3 Activity
title_full The Structural Determinants of Insulin-Like Peptide 3 Activity
title_fullStr The Structural Determinants of Insulin-Like Peptide 3 Activity
title_full_unstemmed The Structural Determinants of Insulin-Like Peptide 3 Activity
title_short The Structural Determinants of Insulin-Like Peptide 3 Activity
title_sort structural determinants of insulin-like peptide 3 activity
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356098/
https://www.ncbi.nlm.nih.gov/pubmed/22654853
http://dx.doi.org/10.3389/fendo.2012.00011
work_keys_str_mv AT bathgaterossad thestructuraldeterminantsofinsulinlikepeptide3activity
AT zhangsoude thestructuraldeterminantsofinsulinlikepeptide3activity
AT hughesricharda thestructuraldeterminantsofinsulinlikepeptide3activity
AT rosengrenkjohan thestructuraldeterminantsofinsulinlikepeptide3activity
AT wadejohnd thestructuraldeterminantsofinsulinlikepeptide3activity
AT bathgaterossad structuraldeterminantsofinsulinlikepeptide3activity
AT zhangsoude structuraldeterminantsofinsulinlikepeptide3activity
AT hughesricharda structuraldeterminantsofinsulinlikepeptide3activity
AT rosengrenkjohan structuraldeterminantsofinsulinlikepeptide3activity
AT wadejohnd structuraldeterminantsofinsulinlikepeptide3activity